Eli Lilly, announced an investment exceeding $1 billion to establish new contract manufacturing operations in India.
Central to this initiative is the development of a major manufacturing and quality facility in Hyderabad, Telangana. This multi-year investment represents one of the most significant commitments by a global drug maker in India iand is aimed at expanding worldwide access to Lilly’s medicines while reinforcing its supply chain capabilities.
The announcement builds on the momentum from the launch of Lilly’s Global Capability Center (GCC) in Hyderabad earlier in August. The new facility will play an important role in supporting the production and distribution of medications for chronic and complex conditions such as diabetes, obesity, cancer, Alzheimer’s disease, and autoimmune disorders.
Lilly plans to collaborate with local contract manufacturers and suppliers, further integrating Indian expertise into its global operations. The facility is expected to enhance production capacity and technical capabilities, positioning Hyderabad as a key node in Lilly’s international supply network.
Lilly already operates a commercial site in Gurgaon, located near Delhi, and has specialized facilities in Bangalore and Hyderabad, which support its global functions. The new manufacturing hub will deepen the company’s footprint in India and foster innovation and efficiency in pharmaceutical production.
Patrik Jonsson, Executive Vice President and President of Lilly International, emphasized that the investment reflects the company’s confidence in India’s strategic importance within its global network. By leveraging India’s skilled workforce and expanding infrastructure, Lilly will fulfil rising global demand for its therapies and contribute to improved health outcomes worldwide.
This initiative not only underscores India’s growing role in global pharmaceutical manufacturing but also signals a broader trend of multinational companies investing in the country’s healthcare and life sciences sectors.
Last updated: December 26th, 2025
